Business Insights, Jan 2008, Pages: 253
is forecast to grow at a rate of 35% over the next five years, the highest growth of any bioinformatics sector. The potential for widespread integration throughout all stages
of drug discovery will act
Jain PharmaBiotech, Feb 2012, Pages: 299
developing them. Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer. Nextgeneration sequencing technologies, both second and third
Frost & Sullivan, Dec 2010, Pages: 61
worked on in the new platforms.” The urge to sequence complex and variable human genomes has created opportunities for the growth of nextgeneration sequencing in areas like gene discovery, gene expression
Takeda Pacific, May 2011, Pages: 161
- Opportunities or Implications for Japan and Asia
7. Profiles of Companies in NextGeneration Sequencing
- 23andMe, Inc.
- 454 Life Sciences (Roche)
- Affymetrix, Inc.
- BioTeam, Inc.
- DeCODE genetics, Inc
John Wiley and Sons Ltd, Feb 2010, Pages: 248
.10 Open access to research information and outcomes
10.11 Systems-based approaches
10.12 Training a new generation of researchers for translational bioinformatics
10.13 Maximizing the use of public
Global Industry Analysts, Inc., Oct 2008, Pages: 675
), Biochip, Proteomics, Genomics, Bioinformatics, Pharmacogenomics, and Other Drug Discovery Technologies (Include Combinatorial Chemistry, Nanotechnology and RNAi). The report provides separate comprehensive
Business Insights, March 2010, Pages: 185
The key factor in the current scenario for next-generation omics-based diagnostic technologies is the level of accuracy in the results, followed by the capacity to detect early, and cost. Cost
Jain PharmaBiotech, Feb 2012, Pages: 225
Combination of FISH and gene chips
Combination of CGH+SNP microarrays
SignatureChip®
Molecular Combing
High density oligonucleotide arrays
NextGeneration Screening®
Comparative genomic hybridization
Fuji-Keizai USA, Inc., July 2008, Pages: 137
Institute’s Cancer Genome Project
6.3.6 The Yanhuang Project
6.4 Next-Generation Genome Sequencing Business Opportunities or Implications
6.4.1 Opportunities or Implications for the US
Table 20
Frost & Sullivan, Oct 2000
-emergent stage, there are no clear dominant suppliers of instrument and supplies, services, or bioinformatics, which creates many opportunities for innovation from both the technological and business
Frost & Sullivan, July 2010, Pages: 83
and cutting-edge technologies,” notes the analyst of this research service. “As expected, the highly sought-after technologies include confocal microscopes, mass spectrometers, and next-generation sequencers
Fuji-Keizai USA, Inc., July 2008, Pages: 137
Institute’s Cancer Genome Project
6.3.6 The Yanhuang Project
6.4 Next-Generation Genome Sequencing Business Opportunities or Implications
6.4.1 Opportunities or Implications for the US
Table 20
Business Insights, Oct 2007, Pages: 161
translational medicine can positively influence the impact of biomarkers, innovations in clinical trial designs and the IT systems that support these functions. The report will identify how data generated from
Markets and Markets, Sep 2009, Pages: 256
The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities
GlobalData, Feb 2012, Pages: 34
transgenic services and solutions. The company maintains four division, namely, Sequencing division, which offers custom DNA sequencing services, next-generation sequencing services, oligoneucliotides, whole
